Tag:
Cardioxyl Pharmaceuticals
Latest Headlines
Latest Headlines
Cardioxyl gets $15M and positive data on lead program
Cardioxyl Pharmaceuticals has rounded up $15 million and positive early-stage safety data, positioning the start-up developer for a mid-stage clinical trial of its lead therapy for cardiovascular
